Clear and slow movement supports stability during the early stages
Likely in the same way, along with encephalopathies [33,34,35,36,37,38,39,40,41], BPC 157 counteracts multiple pathology in the gastrointestinal tract and liver [33,34,35,36,37,38,39,40,41], and various arrhythmias [73,74,75,76,77] (in particular, BPC 157 therapy normalizes the QTc duration in rats treated with neuroleptics and prevents and recovers chronic heart failure [75,76])
Amidation (C-terminal): Neutralizes the negative charge at the end of the peptide chain, frequently improving biological activity and receptor interactions
Simon A, Wegrowski Y, Bontemps Y, et al
Hormonal changes extend beyond metabolic hormones